Episode Transcript
[00:00:11] Speaker A: In the quiet of a cradle, a bright screen starts to shout Numbers climbing like a siren.
[00:00:20] Speaker B: Welcome to Base by Bass, the papercast that brings genomics to you wherever you are. Thanks for listening and thank you. And don't forget to follow and rate us in your podcast app.
So imagine looking at a massive, incredibly complex factory.
[00:00:33] Speaker C: Okay, I'm picturing it.
[00:00:34] Speaker B: You see the assembly line workers physically putting the products together. Right.
And you decide that they are the only ones who matter. You completely ignore the management team, the safety inspectors, the architects, and the entire
[00:00:47] Speaker C: master control room just because they aren't like, physically holding a wrench.
[00:00:51] Speaker B: Exactly. And for decades, that is essentially what we've been doing with human genetics.
When scientists looked at the human genome, they hyper focused on the protein coding genes, the ones that actually build the tangible structures of our bodies.
[00:01:04] Speaker C: Right, the assembly line workers.
[00:01:06] Speaker B: Yeah. And the rest of it, which is an astounding 98% of our DNA, was largely dismissed. Have you ever wondered why scientists used to literally call it junk DNA?
[00:01:15] Speaker C: Oh, it was pure hubris. The prevailing assumption for a very long time, but was that if a sequence of DNA didn't, you know, actively encode a protein, it was just evolutionary baggage.
[00:01:26] Speaker B: It was just taking up space.
[00:01:27] Speaker C: Yeah, exactly. It was viewed as the leftover scraps of millions of years of cellular history doing absolutely nothing of value.
[00:01:35] Speaker B: But we're realizing how incredibly wrong that assumption was.
Today's deep dive is going to take us right in the heart of that 98%, the so called dark matter of our genome, to show how it is actively orchestrating our biology.
[00:01:49] Speaker C: It's a fascinating shift in perspective.
[00:01:51] Speaker B: It really is. We're looking at a groundbreaking 2026 paper published in the American Journal of Human Genetics by Johnson and colleagues. And today we really want to celebrate the work of this research team who have fundamentally advanced our understanding of monogenic diabetes and non coding rna.
[00:02:07] Speaker C: Absolutely. The work they did across multiple international institutions to put this together is just stellar.
[00:02:12] Speaker B: And the whole story starts with a profoundly baffling, heartbreaking clinical mystery. It's a problem that forced these researchers to look into the dark matter to find an answer.
Okay, let's unpack this. What were we looking at?
[00:02:26] Speaker C: Well, the clinical picture here is, it's striking.
The researchers were dealing with a cohort of infants who appeared relatively healthy at birth, but then developed extremely severe diabetes at just 13 to 36 weeks of age.
[00:02:39] Speaker B: Wow, barely a few months old.
[00:02:41] Speaker C: Right. We are talking about tiny babies requiring around 1.0 units per kg per day of full insulin replacement, which Is a
[00:02:50] Speaker B: massive life sustaining dose for an infant.
[00:02:52] Speaker C: It's a huge dose. And it wasn't just the diabetes. That alone in an infant is rare and alarming. But these babies were also experiencing bizarre, unexplained immune system failures right alongside it.
[00:03:02] Speaker B: So they were getting sick on top of the diabetes and.
[00:03:04] Speaker C: Exactly. Their blood work showed a condition called hypogammaglobulinemia. In straightforward terms, they had dangerously low levels of antibodies, Leaving them incredibly vulnerable to infections.
[00:03:16] Speaker B: Okay, so when a clinical team sees a combination like that, Severe early onset diabetes and simultaneous immune system failure in an infant, what's the protocol?
[00:03:27] Speaker C: The immediate protocol is to run full whole genome sequencing. You're looking for a monogenic cause, Like
[00:03:33] Speaker B: a single catastrophic genetic mutation. That explains everything.
[00:03:36] Speaker C: Exactly. So they combed through all the known protein coding genes Associated with infancy onset diabetes and immune deficiencies. They looked at the blueprints for those assembly line workers, and they found absolutely nothing. Every single structural protein coding gene was perfectly intact.
[00:03:52] Speaker B: Which means the blueprints for the workers were fine. The problem had to be in the control room.
[00:03:57] Speaker C: Right. So the researchers shifted their focus to the non coding regions. They started searching for ultra rare mutations in the dark matter, and they finally
[00:04:04] Speaker B: found the culprit, hiding in a non coding gene called RNG NU6ATE.
[00:04:10] Speaker C: But this presents a massive hurdle for anyone trying to understand the science here, right?
[00:04:14] Speaker B: It does. Yeah.
[00:04:15] Speaker C: If RNU6ATEC is a non coding gene, meaning it never gets translated into a protein, what is it actually doing inside the cell? To understand its function, we have to look at a highly specialized piece of cellular machinery called the minor spliceosome. Let's trace the normal path of genetics for a second.
[00:04:32] Speaker B: Okay, lay it out for us.
[00:04:34] Speaker C: When your DNA is read, it's transcribed into a raw preliminary form of rna. But that raw RNA is full of interruptions. It contains sections called introns, which are essentially segments of genetic gibberish that break up the actual instruction.
[00:04:49] Speaker B: Right, the typos.
[00:04:50] Speaker C: Exactly.
Before that RNA can be used to build a protein, those introns have to be meticulously cut out. And the meaningful parts, the exons, have to be spliced together.
[00:05:01] Speaker B: Okay, so let me make sure I'm visualizing this. Right. For our listeners. If a normal protein coding gene is like a recipe for a cake, you read the recipe, you bake the cake. This non coding gene is doing something entirely different.
[00:05:13] Speaker C: It's not baking anything.
[00:05:14] Speaker B: Right. It's more like a recipe for a pair of microscopic scissors. And the entire job of those scissors is to cut the typos out of the other recipes before the chef is allowed to read them.
[00:05:23] Speaker C: That captures the dynamic perfectly.
RNU6ATAK is a type of small nuclear RNA. It doesn't make a protein. The RNA strand itself folds into a complex three dimensional shape and acts as the literal cutting blade of those microscopic scissors.
[00:05:39] Speaker B: That is wild.
[00:05:40] Speaker C: It really is. Now, our cells have a standard major spliceosome that handles the vast majority of these typo cutting jobs. But the minor spliceosome, the one RNU6ADAC operates in, is highly conserved and incredibly specialized.
[00:05:55] Speaker B: How specialized are we talking?
[00:05:57] Speaker C: It handles less than half a percent of our introns. Specifically these rare ones known as U12 type introns.
[00:06:03] Speaker B: But those rare typos aren't just scattered randomly, are they?
[00:06:06] Speaker C: No, not at all. They are found in about 700 very specific, highly important genes across the human
[00:06:11] Speaker B: body and in the infants suffering from this severe diabetes and immune failure. Both inherited copies of their RNU6 ATAK gene carried rare pathogenic mutations, right?
[00:06:21] Speaker C: Yes. The cutting blade was fundamentally broken.
[00:06:24] Speaker B: Which immediately leads to the next logical step. If the cutting blade of this machinery is breaking and causing these severe symptoms, what about the rest of the machinery?
[00:06:31] Speaker C: Right, because a pair of scissors isn't just a blade.
[00:06:33] Speaker B: Exactly. There's a handle, there's a pivot point. The minor splice of some isn't just a single gene acting alone.
[00:06:39] Speaker C: It relies on a massive complex of interacting components. And recognizing this, the researchers broadened their net. They gathered a larger cohort of 276 infants from around the world, who all had unexplained early onset diabetes.
[00:06:55] Speaker B: So they screened this larger group for mutations across the other 64 genes that make up the minor spliceism complex.
[00:07:03] Speaker C: And they found something incredible. They found 12 completely unrelated individuals in that group who had inherited mutations on both copies of a partner gene called RNU4ATAC.
[00:07:13] Speaker B: So another non coding gene, how does that one fit in?
[00:07:15] Speaker C: Well, the relationship between these two genes is an elegant piece of molecular biology. RNU4ATK functions as a safety sheath and a stabilizer.
[00:07:24] Speaker B: A sheath for the scissors.
[00:07:25] Speaker C: Precisely. Before the minor spliceosome can make its precise cut on the RNA, RNU4ATAK has to bind directly to RNU6ATAK. It holds the blade in the exact pre catalytic configuration required. It keeps the mechanism stable until the precise moment the cut needs to happen.
[00:07:43] Speaker B: Now, medical science actually knew about RNU4 ATAK mutations before this, didn't they?
[00:07:47] Speaker C: Yes. They were known to cause a condition called RNU4ATC opathy, which typically presents with microcephaly developmental delays and severe growth restrictions.
[00:07:56] Speaker B: But this paper marks the very first time that researchers have definitively linked mutations in this non coding partner gene to early onset autoimmune diabetes.
[00:08:06] Speaker C: That's the breakthrough. In these 12 infants, the. The median onset for their diabetes was just 20 weeks old.
[00:08:11] Speaker B: Wait, hold on. I'm stuck on something here.
[00:08:12] Speaker C: What's that?
[00:08:13] Speaker B: We have these two non coding RNAs working together intimately. Breaking either one of them causes these babies to develop incredibly severe localized diabetes, completely destroying their pancreas. But you just mentioned that this Minor splicism edits 700 different genes all over the human body.
[00:08:30] Speaker C: So how does a generic splicing error, a broken pair of scissors that affects 700 different instruction manuals, result in such a specific targeted destruction of the insulin producing cells? Like, why isn't every single organ system in the baby's body just failing all at once?
[00:08:48] Speaker B: That is the core paradox of this entire condition. You have a systemic genetic error happening in every cell. But a highly localized, highly specific clinical disaster, right?
[00:08:58] Speaker C: It doesn't seem to make sense.
[00:09:00] Speaker B: The answer lies in how different biological systems tolerate genetic stress.
Some organ systems can limp along with a few improperly edited proteins.
[00:09:08] Speaker C: Like they can handle a few typos.
[00:09:10] Speaker B: Exactly. But the human immune system relies on incredibly rapid, massive cellular proliferation and highly sensitive chemical signaling to mature properly. If the blueprints for immune cell development have even a tiny typo left in them, that specific assembly line jams up far more catastrophically than, say, a muscle cell would. So to prove that, the researchers had to actually look at what the broken scissors were leaving behind on the factory floor. They had to transition from looking at the DNA to looking at the RNA being produced in the blood cells.
[00:09:40] Speaker C: And that's where the methodology gets really cool. They performed whole blood RNA sequencing on
[00:09:44] Speaker B: the patients, and what did they find?
[00:09:46] Speaker C: When they look at the readouts, they found widespread intron retention across 274 different genes.
[00:09:55] Speaker B: Intron retention? Meaning the junk was still there.
[00:09:58] Speaker C: Exactly. Because the minor spliceosome was broken, the U12 junk text wasn't being spliced out. It was being left inside the mature rna. Meaning the cellular machinery was trying to build proteins using instructions that still had massive paragraphs of gibberish in them.
[00:10:13] Speaker B: Here's where it gets really interesting. When they took all that messy, improperly spliced RNA data and ran it through a network analysis, basically grouping the data to find the common denominator of. Of what was actually breaking down the results Were stunning.
[00:10:28] Speaker C: What's fascinating here is that the affected genes didn't just cause random chaos across the body. The errors bottlenecked and converged specifically on one critical system.
[00:10:38] Speaker B: B cell signaling and development.
[00:10:39] Speaker C: Yes, and the multi omic validation of this is what makes the study so robust. They didn't just stop at RNA sequencing. They validated those findings using DNA methylation data from 17 affected individuals.
[00:10:52] Speaker A: And.
[00:10:52] Speaker C: And then took it a step further.
[00:10:54] Speaker B: What did they do next?
[00:10:55] Speaker C: They performed fresh blood flow cytometry on a patient with the RNU4ATK mutation.
[00:11:00] Speaker B: Oh, for anyone who hasn't spent time in a hematology lab, Flow cytometry is an incredible piece of technology.
[00:11:06] Speaker C: It really is.
[00:11:07] Speaker B: Imagine taking a sample of blood, tagging the cells with specific fluorescent markers, and then forcing those cells to pass single file through a laser beam. The laser hits the markers, and the machine can literally count and sort living cells one by one based on their exact type and stage of development.
[00:11:23] Speaker C: It gives you a high definition snapshot of the living immune system. And the flow cytometry results for this patient were undeniable. They showed a severe fundamental lack of what we call naive B cells.
[00:11:34] Speaker B: Naive B cells being the fresh recruits of the immune system. They are the blank slates that haven't been programmed to attack a specific target yet.
[00:11:42] Speaker C: Right. They're the foundational population of the adaptive immune system.
But while the patient was entirely lacking these fresh recruits, their blood showed a massive chaotic excess of transitional B cells and mature antibody secreting cells.
[00:11:57] Speaker B: So the pipeline is completely jammed.
[00:11:59] Speaker C: The development pipeline of their immune system is fundamentally broken because the minor spliceosome is leaving junk in the instructions required to build and mature these cells. The B cells are failing to develop properly.
[00:12:12] Speaker B: You know, if you've ever wondered why your immune system occasionally makes a mistake and goes rogue, this is a literal backdoor into understanding it. We aren't just talking about a rare disease anymore. This is mapping the hidden circuitry of human immunity.
[00:12:25] Speaker C: It really is. A microscopic error in the non coding dark matter completely derails immune maturation. It provides undeniable proof that immune tolerance, the fragile ability of your body to recognize itself and not attack its own tissue, and is heavily dependent on these tiny, seemingly invisible regulatory mechanisms.
[00:12:44] Speaker B: But this introduces another massive paradox that really requires some unraveling. Let's connect this jammed B cell pipeline back to the clinical diabetes symptoms. The researchers proved that this diabetes is definitively autoimmune, right?
[00:12:58] Speaker C: Yes, absolutely. 50% of the tested infants were positive for GATA, which are glutamic acid decarboxylase, autoantibodies.
[00:13:06] Speaker B: Okay, so this means their immune system is actively deliberately hunting down and destroying their pancreas. Identical to classic type 1 diabetes.
[00:13:14] Speaker C: Exactly. Identical.
[00:13:15] Speaker B: Yeah, but. And here is the paradox. If they're B cells, the specific factories whose entire biological purpose is to manufacture antibodies, if they are depleted or completely malfunctioning, how are they successfully producing precision autoantibodies that destroy the pancreas?
[00:13:30] Speaker C: It's a great question.
[00:13:31] Speaker B: If the weapons factory is broken, how are the missiles still firing?
[00:13:35] Speaker C: You've just hit on one of the most fiercely debated topics in modern immunology.
What is the actual primary driver of autoimmune diabetes?
[00:13:44] Speaker B: Right.
[00:13:44] Speaker C: If we connect this to the bigger picture, some researchers argue that B cells are the primary culprits, that they directly lead the charge and cause the destruction. But a growing counter argument is that the B cell dysregulation we can measure is actually just a secondary symptom of a much bigger, broader immune system collapse.
[00:14:01] Speaker B: And the authors of this paper bring up a fascinating piece of medical history to contextualize this debate.
[00:14:07] Speaker C: Yeah. They reference a documented case of a patient with a condition called X linked gamma globulinemia, or xla.
[00:14:14] Speaker B: What does that do?
[00:14:15] Speaker C: This is a genetic condition where a person is born completely lacking the ability to form B cells. They have absolutely zero antibody factories.
[00:14:23] Speaker B: Not at all.
[00:14:24] Speaker C: None. And yet that specific, specific patient still developed autoimmune diabetes.
[00:14:28] Speaker B: Wait, really? A patient with no B cells whatsoever still had their immune system attack their pancreas?
[00:14:33] Speaker C: Exactly. It implies a radical shift in how we view the disease.
While autoantibodies are a fantastic, measurable biomarker for diagnosing diabetes, they might not be the primary weapon actually executing the destruction of the pancreas.
[00:14:48] Speaker B: So it is.
[00:14:49] Speaker C: The data from this paper suggests that. That the sheer dysregulation of the immune system is the true culprit.
Go back to that flow cytometry data. The infants lacked naive B cells, but had a chaotic excess of transitional cells.
[00:15:04] Speaker B: So it's not simply a deficiency. It is total systemic chaos.
[00:15:07] Speaker C: Yes.
The normal delicate checks and balances of the immune system have completely evaporated.
[00:15:13] Speaker B: It's like. It's like removing all the traffic lights in a bustling, crowded city. The cars, meaning the other immune cells, like T cells, are still functioning perfectly fine. Their engines work, their steering work.
[00:15:24] Speaker C: Right. They can still drive.
[00:15:25] Speaker B: But without the dispatcher, without the automated signals keeping everything in check and telling them when to stop, massive crashes are inevitable. The non coding DNA was supposed to be the master dispatcher keeping the traffic grid organized.
[00:15:38] Speaker C: And because that dispatcher is fundamentally broken at the genetic level, because of the RNU6ATAC or RNU4ATAK mutations leave U12 introns lingering in the RNA. The proteins needed for B cell signaling are built incorrectly.
[00:15:53] Speaker B: The traffic lights go dark, the immune
[00:15:55] Speaker C: system loses its tolerance, the traffic lights go dark, and the body's T cells likely go rogue, attacking the insulin producing cells of the pancreas. It is a stunning unbroken cascade of
[00:16:06] Speaker B: causality from start to finish.
[00:16:08] Speaker C: We can trace it from a single single nucleotide change in the dark matter of the genome, all the way up to an infant requiring daily insulin injections to survive.
[00:16:18] Speaker B: So what does this all mean? Let's take a step back and look at the monumental nature of what this research team has accomplished. For the very first time in medical history, scientists have definitively proven that monogenic single gene autoimmune diabetes can be caused by nine protein coding genes.
[00:16:33] Speaker C: It's a huge milestone.
[00:16:35] Speaker B: By identifying these variants in the minor spliceism, they haven't just put push the boundaries of molecular biology. They have solved a deeply painful, terrifying medical mystery for 16 families around the world.
[00:16:46] Speaker C: And that human impact is profound.
These were families who watched their babies suffer from severe diabetes and unexplained infections, only to be told by standard genetic testing that their blueprints were normal. Because the protein coding genes looked fine.
[00:17:02] Speaker B: Ending that diagnostic odyssey is immeasurably valuable.
It gives those families an answer. It opens the door for accurate genetic counseling.
[00:17:10] Speaker C: And on a macro level, it completely shifts the paradigm of how we must approach undiagnosed autoimmune conditions moving forward. We can no longer afford to only look at the 2% of the genome that builds proteins.
[00:17:22] Speaker B: The dark matter is no longer junk. It is an active vital control room, constantly orchestrating the health balance and maturation of our entire immune system system.
[00:17:31] Speaker C: Which leaves us with a truly profound implication for the future of medicine. I mean, we are currently living in the dawn of the gene editing era, right?
[00:17:39] Speaker B: Things like crispr.
[00:17:40] Speaker C: Exactly. Technologies like CRISPR are being developed to cure diseases by fixing broken protein coding genes, essentially trying to repair the broken factory workers on the assembly line. But we just learned that a tiny invisible mutation in a non coding RNA that handles less than half a percent of our genetic splicing can cause the human immune system to completely self destruct.
[00:18:03] Speaker B: It really forces you to wonder if the true master switches of our immune tolerance are hiding in the 98% of our DNA that we used to ignore. Will the future of gene therapy require a massive pivot?
[00:18:15] Speaker C: That's the million dollar question.
[00:18:17] Speaker B: Are we going to realize that curing widespread complex autoimmune diseases like rheumatoid arthritis, lupus, or common type 1 diabetes doesn't mean fixing the bricks of the house, but actually rewriting the invisible dark matter that tells the body how to build it?
[00:18:31] Speaker C: It strongly suggests the answers we've been desperately searching for have been waiting in the dark all along. Are we looking for our lost keys under the streetlight of protein coding genes just because that's where the light is?
[00:18:40] Speaker B: I have a feeling the master control room is finally about to step into the spotlight. That's all the time we have for this deep dive.
[00:18:47] Speaker C: Keep questioning those blueprints this episode was
[00:18:50] Speaker B: based on an Open Access article under the CC BY 4.0 license.
You can find a direct link to the paper and the license in in our episode description. If you enjoyed this, follow or subscribe in your podcast app and leave a five star rating. If you'd like to support our work, use the donation link in the description Now. Stay with us for an original track created especially for this episode and inspired by the article you've just heard about. Thanks for listening and join us next time as we explore more science base by base.
[00:19:31] Speaker A: In the quiet of a cradle A bright screen starts to shout Numbers climbing like a siren no one knows what it's about Deep inside the tiny letters Someone skips the hidden beat A smaller kind of splice is stumbling underneath it's not a broken protein, it's a whisper in the code Little RNAs in the shadows carrying a load and when the myths are turning Whole pages don't align A thread gets pulled across the bloodline when the small machine snap the whole song turns Strange intro left behind and the rhythm rewreps changed from the lab's cold light to the wall's long night we trace the missing stitches till the meaning comes alive yeah, the small machine slips but we're reading it right
[00:20:50] Speaker B: A
[00:20:50] Speaker A: map of family branches, a pattern in the lines Two quiet variants meeting and the timing's infantile Signals in the bloodstream like static in the air Half of them with markers that say the fight is there Naive automatic learning how to grow but the lesson gets distorted when the splicing won't flow we're dancing like a shadow on a hundred genes or more we don't have every answer still we found the door so test the hidden letters don't stop at what you see the smallest blast can name the storm and start the remedy?
When the small machine slaps the whole song turns strange?
You, 12 left behind and the rhythm rearranged but we turn the lights on Follow every sign from the first hard weeks to the root of the design, yeah, the slow machine SL.
Now we're drawing the line, Sam.
